Home »
Hypermutation is an unusual occurence that can lead to many nearby mutations at once, severely damaging our genetic material and potentially causing cancer. The best known type of local hypermutation, called a mutation shower or
Scientists at Imperial College London say they are immunizing hundreds of people with an experimental coronavirus vaccine in an early trial after seeing no worrying safety problems in a small number vaccinated so far. Dr.
Scientists and historians working at McMaster University, the Mütter Museum and the University of Sydney have pieced together the genomes of old viruses that were used as vaccination strains during and after the American Civil
Cancer researchers at Children’s Hospital of Philadelphia (CHOP) have harnessed tools used for the development of cancer immunotherapies and adapted them to identify regions of the SARS-CoV-2 virus to target with a vaccine, employing the
South Australian scientists have made a critical breakthrough, discovering how an obscure protein causes breast cancer to develop and grow more quickly. High levels of a protein called Creld2 have been linked to the most
An international team of researchers has developed a new mathematical tool that could help scientists to deliver more accurate predictions of how diseases, including COVID-19, spread through towns and cities around the world. Rebecca Morrison,
Researchers from the Shenzhen Institutes of Advanced Technology (SIAT) of the Chinese Academy of Sciences have developed a new strontium-substituted bioactive glass (BG) bone cement that optimizes the concentration of strontium to improve peri-implant bone
Scientists discover mysterious never-before-seen virus in a lake in Brazil – and name it after a mermaid who lured soldiers underwater to their death Yaravirus is named after Yara, a supernatural mermaid in Brazil Over
Scientists in the city at the center of China’s virus outbreak have applied to patent a drug made by U.S. company Gilead Science Inc. to treat the disease, possibly fueling conflict over technology policy that
HIV vaccine could be available by 2021 as scientists tackling the AIDS-causing virus reveal they are ‘optimistic’ about three ongoing trials HVTN 702, Imbokodo and Mosaico are in trial with results as early as 2020